Chronic myeloid leukemia (CML), a clonal myeloproliferative disease is known to develop from a pluripotent bone-marrow stem cell following the typical BCR and ABL somatic gene rearrangement. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.